SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Income Before Tax

Profit after all operating and non-operating items but before income tax.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax of -$13.82M in Q1 FY2026

Q1 FY2026 income before tax was -$13.82M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$13.82M-10.1% QoQ
Last fiscal yearDec 2025
-$39.87M— YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
(39.87M) USD
Year-over-year change
—

Income Before Tax vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Income Before Tax for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$781.34M USD-37.2%+35.8%7.1%
STAASTAAR Surgical CompanyLTM Apr 2026-$19.56M USD+68.1%—6.7%
SGHTSight Sciences, Inc.LTM Mar 2026-$37.27M USD+24.1%—46.9%
SGPSpyGlass Pharma, Inc. Common StockFY2025-$39.87M USD———
RXSTRxSight, Inc.LTM Mar 2026-$46.58M USD-75.9%—36.5%
BLCOBausch + Lomb CorporationLTM Jun 2026-$65M USD+83.5%—1.2%
OCSOculis Holding AGLTM Mar 2026-CHF 95.35M CHF+7.5%—18919.2%
GKOSGlaukos CorporationLTM Jun 2026-$192.83M USD-109.2%—31.5%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026-$271.37M USD-85.0%—3563.6%
OCULOcular Therapeutix, Inc.LTM Mar 2026-$290.5M USD-50.7%—558.2%
Peer median (excluding SGP) —-37.2%+35.8%36.5%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.